De novo neonatal antiphospholipid syndrome: A case report and review of the literature

Seminars in Arthritis and Rheumatism

Volumn 44, Issue 2, 2014, Pages 241-245

  Gordon, Oren ^a   Almagor, Yotam ^a   Fridler, Dvora ^a   Mandel, Asaf ^a   Qutteineh, Hiba ^a   Yanir, Asaf ^a   Reif, Shimon ^a   Revel Vilk, Shoshana ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Antiphospholipid syndrome; Neonatal thrombosis

Indexed keywords

ANTIBIOTIC AGENT; ANTINUCLEAR ANTIBODY; ANTITHROMBIN; BETA2 GLYCOPROTEIN 1 ANTIBODY; BLOOD CLOTTING FACTOR 5 LEIDEN; C REACTIVE PROTEIN; CARDIOLIPIN ANTIBODY; D DIMER; HEMOGLOBIN; HEPARIN; HOMOCYSTEINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; PROTEIN C; PROTEIN S; PROTHROMBIN; ANTICOAGULANT AGENT; PHOSPHOLIPID ANTIBODY;

ACUTE KIDNEY FAILURE; ANTIBIOTIC THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CULTURE; CASE REPORT; DEEP VEIN THROMBOSIS; DOPPLER FLOWMETRY; ECHOCARDIOGRAPHY; ELBOW SWELLING; ERYTHROCYTE SEDIMENTATION RATE; FEVER; FLUID RESUSCITATION; FLUID THERAPY; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HIP DYSPLASIA; HIP SPICA; HUMAN; INFANT; KIDNEY FAILURE; LEUKOCYTE COUNT; MALE; METABOLIC ACIDOSIS; NEONATAL ANTIPHOSPHOLIPID SYNDROME; NEWBORN; NEWBORN DISEASE; OSTEOMYELITIS; PARTIAL THROMBOPLASTIN TIME; PERIPHERAL PULMONARY STENOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; PULMONARY VALVE STENOSIS; RANGE OF MOTION; SWELLING; THROMBOCYTOPENIA; THROMBOPHILIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; URINALYSIS; URINE CULTURE; UROSEPSIS; BLOOD; DIFFERENTIAL DIAGNOSIS; IMMUNOLOGY; THROMBOSIS; TREATMENT OUTCOME;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; DIAGNOSIS, DIFFERENTIAL; HUMANS; INFANT; MALE; THROMBOSIS; TREATMENT OUTCOME;

EID: 84927579912     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2014.04.003     Document Type: Article

References (30)

1. Greenway A., Massicotte M.P., Monagle P. Neonatal thrombosis and its treatment. Blood Rev 2004, 18:75-84.
2. Nowak-Gottl U., Janssen V., Manner D, Kenet G. Venous thromboembolism in neonates and children-update 2013. Thromb Res 2013, 131(Suppl 1):S39-S41.
3. Schmidt B., Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995, 96:939-943.
4. Yang J.Y., Chan A.K. Neonatal systemic venous thrombosis. Thromb Res 2010, 126:471-476.
5. Van Ommen C.H., Heijboer H., Buller H.R., Hirasing R.A., Heijmans H.S., Peters M. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr 2001, 139:676-681.
6. Revel-Vilk S., Kenet G. Thrombophilia in children with venous thromboembolic disease. Thromb Res 2006, 118:59-65.
7. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4:295-306.
8. Hanly J.G. Antiphospholipid syndrome: an overview. Can Med Assoc J 2003, 168:1675-1682.
9. Levine J.S., Branch D.W., Rauch J. The antiphospholipid syndrome. N Engl J Med 2002, 346:752-763.
10. Cervera R., Piette J.C., Font J., Khamashta M.A., Shoenfeld Y., Camps M.T., et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 2002, 46:1019-1027.
11. Paro-Panjan D., Kitanovski L., Avcin T. Neonatal antiphospholipid syndrome associated with heterozygous methylentetrahydrofolate reductase C677T and prothrombin G20210A gene mutations. Rheumatology (Oxford) 2007, 46:720-721.
12. Boffa M.C., Lachassinne E. Infant perinatal thrombosis and antiphospholipid antibodies: a review. Lupus 2007, 16:634-641.
13. Bhat M.A., Kawoosa M.S., Bhat J.I., Ali S.W. Antiphospholipid syndrome in a neonate. Pediatr Dermatol 2011, 28:342-345.
14. Berkun Y., Padeh S., Barash J., Uziel Y., Harel L., Mukamel M., et al. Antiphospholipid syndrome and recurrent thrombosis in children. Arthritis Rheum 2006, 55:850-855.
15. De Carolis M.P., Salvi S., Bersani I., De Carolis S. Isolated cerebral sinovenous thrombosis: a rare case of neonatal antiphospholipid syndrome. Indian Pediatr 2012, 49:411-412.
16. Ebeling F., Petaja J., Alanko S., Hirvasniemi A., Holm T., Lahde M., et al. Infant stroke and beta-2-glycoprotein 1 antibodies: six cases. Eur J Pediatr 2003, 162:678-681.
17. Rego Sousa P., Figueira R., Vasconcellos R. Neonatal stroke associated with de novo antiphospholipid antibody and homozygous 1298C/C methylenetetrahydrofolate reductase mutation. BMJ Case Rep 2012, 2012.
18. Merlin E., Dore E., Chabrier S., Biard M., Marques-Verdier A., Stephan J.L. A case of infantile de novo primary antiphospholipid syndrome revealed by a neonatal arterial ischemic stroke. J Child Neurol 2012, 27:1340-1342.
19. Cabral M., Abadesso C., Conde M., Almeida H., Carreiro H. Catastrophic antiphospholipid syndrome: first signs in the neonatal period. Eur J Pediatr 2011, 170:1577-1583.
20. Alshekaili J., Reynolds G., Cook M.C. De novo infantile primary antiphospholipid antibody syndrome. Lupus 2010, 19:1565-1568.
21. Soares Rolim A.M., Castro M., Santiago M.B. Neonatal antiphospholipid syndrome. Lupus 2006, 15:301-303.
22. Motta M., Chirico G., Rebaioli C.B., Faden D., Lojacono A., Allegri F., et al. Anticardiolipin and anti-beta2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: a follow-up study. Am J Perinatol 2006, 23:247-251.
23. Young G. Old and new antithrombotic drugs in neonates and infants. Semin Fetal Neonatal Med 2011, 16:349-354.
24. Saxonhouse M.A. Management of neonatal thrombosis. Clin Perinatol 2012, 39:191-208.
25. Garcia-Carrasco M., Galarza-Maldonado C., Mendoza-Pinto C., Escarcega R.O., Cervera R. Infections and the antiphospholipid syndrome. Clin Rev Allergy Immunol 2009, 36:104-108.
26. Ben-Chetrit E., Wiener-Well Y., Fadeela A., Wolf D.G. Antiphospholipid antibodies during infectious mononucleosis and their long term clinical significance. J Clin Virol 2013, 56:312-315.
27. Von Landenberg P., Lehmann H.W., Knoll A., Dorsch S., Modrow S. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Arthritis Rheum 2003, 48:1939-1947.
28. Rizzi M.B.C. A diagnostic approach to a child with thrombosis. Sickkids handbook for pediatric thrombosis and hemostasis 2013, Karger, Basel. V.S. Blanchette, V.R. Breaky, S. Revel-Vilk (Eds.).
29. Ignjatovic V., Kenet G., Monagle P. Developmental hemostasis: recommendations for laboratories reporting pediatric samples. J Thromb Haemost 2012, 10:298-300.
30. Pengo V., Tripodi A., Reber G., Rand J.H., Ortel T.L., Galli M., et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009, 7:1737-1740.